American Century Companies Inc. Has $6.82 Million Stake in Koninklijke Philips N.V. $PHG

Key Points

• American Century Companies Inc. reduced its holdings in Koninklijke Philips N.V. by 9.1%, bringing its total to 268,410 shares valued at approximately $6.82 million.
• Positive earnings results were reported, with exceeding analysts' EPS estimates by $0.12, reporting $0.41 per share on revenue of $5.05 billion.
• Wall Street analysts downgraded Koninklijke Philips from a "buy" to a "hold" rating, although the stock still holds a consensus rating of "Buy" from analysts.

American Century Companies Inc. cut its stake in Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 9.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 268,410 shares of the technology company's stock after selling 26,748 shares during the quarter. American Century Companies Inc.'s holdings in Koninklijke Philips were worth $6,818,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. QRG Capital Management Inc. raised its position in shares of Koninklijke Philips by 11.0% in the first quarter. QRG Capital Management Inc. now owns 142,595 shares of the technology company's stock valued at $3,622,000 after purchasing an additional 14,090 shares during the period. Aurora Private Wealth Inc. bought a new position in shares of Koninklijke Philips in the first quarter valued at about $1,695,000. Quantinno Capital Management LP raised its position in shares of Koninklijke Philips by 71.1% in the fourth quarter. Quantinno Capital Management LP now owns 180,149 shares of the technology company's stock valued at $4,561,000 after purchasing an additional 74,835 shares during the period. Cerity Partners LLC raised its position in shares of Koninklijke Philips by 30.6% in the first quarter. Cerity Partners LLC now owns 80,767 shares of the technology company's stock valued at $2,051,000 after purchasing an additional 18,906 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in shares of Koninklijke Philips by 2.5% in the first quarter. Dimensional Fund Advisors LP now owns 4,396,095 shares of the technology company's stock valued at $111,662,000 after purchasing an additional 106,044 shares during the period. 13.67% of the stock is owned by institutional investors.

Koninklijke Philips Stock Performance

Shares of PHG stock traded down $0.54 on Tuesday, hitting $27.05. The company's stock had a trading volume of 590,550 shares, compared to its average volume of 732,663. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.81 and a current ratio of 1.26. The stock's 50 day moving average is $25.92 and its 200-day moving average is $24.99. Koninklijke Philips N.V. has a fifty-two week low of $21.48 and a fifty-two week high of $32.91. The company has a market capitalization of $26.04 billion, a PE ratio of 142.34, a PEG ratio of 0.75 and a beta of 0.81.

Koninklijke Philips (NYSE:PHG - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The technology company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.29 by $0.12. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. The business had revenue of $5.05 billion for the quarter, compared to the consensus estimate of $4.35 billion. Equities research analysts expect that Koninklijke Philips N.V. will post 1.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Wall Street Zen lowered shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Buy".

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.